Trial no.:
|
PACTR202003822626676 |
Date of Approval:
|
17/03/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
erector spinae block in On pump coronary bypass graft surgery |
Official scientific title |
The effect of ultrasound-guided bilateral single shot erector spinae block on recovery after on-pump coronary bypass graft surgery |
Brief summary describing the background
and objectives of the trial
|
Fast-track anesthesia (FTA) is a procedure that enables extubation in intensive care unit (ICU) within 6 h after surgery to facilitate the recovery of consciousness and autonomous breathing. It has been safely applied to cardiac surgery since the 1990s. FTA is feasible and safe and reduces the occurrence of ventilator induced complications, thereby decreasing ICU stay, resource use and cost. Ultra-fast tract anesthesia (UFTA) was developed after fast-track anesthesia to further optimize the use of medical resource. With UFTA, extubation is performed immediately or within 1 h after surgery in the operating room. The benefits of UFTA include lower incidence of postoperative complications, better hemodynamic performance, shorter ICU stay.
Fast track and ultrafast track cardiac anaesthesia can be achieved by reduced opioid doses or opioid free with multimodal analgesia augmented with bilateral regional anaesthesia as erector spinae block (ESP). An ESP block is performed by depositing local anesthetic deep to the erector spinae muscles and superficial to the transverse processes. The block is typically completed under ultrasound guidance and can be performed in cervical, thoracic, or lumbar levels for a wide variety of surgical or chronic pain indications, including cardiothoracic surgery.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
14/03/2020 |
Actual trial start date |
|
Anticipated date of last follow up |
14/03/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
54 |
Actual target sample size (number of participants) |
|
Recruitment status |
Active, not recruiting |
Publication URL |
|
|